Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118779672 | 11877967 | 2 | F | 20160628 | 20151230 | 20160711 | EXP | US-DRREDDYS-USA/USA/15/0055050 | DR REDDYS | GOLOMB B, KOSLIK H, REDD A. FLUOROQUINOLONE-INDUCED SERIOUS, PERSISTENT, MULTISYMPTOM ADVERSE EFFECTS. BMJ CASE REP. 2015;1-10. | 46.00 | YR | M | Y | 0.00000 | 20160711 | MD | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118779672 | 11877967 | 1 | PS | Levofloxacin Tablets | LEVOFLOXACIN | 1 | Unknown | UNKNOWN | 76710 | 750 | MG | QD | |||||||
118779672 | 11877967 | 2 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNKNOWN | 77038 | 10 | MG | ||||||||
118779672 | 11877967 | 3 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 0 | 30 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118779672 | 11877967 | 1 | Epididymitis |
118779672 | 11877967 | 2 | Neuropathy peripheral |
118779672 | 11877967 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
118779672 | 11877967 | DS |
118779672 | 11877967 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118779672 | 11877967 | Affective disorder | |
118779672 | 11877967 | Arthralgia | |
118779672 | 11877967 | Atrophy | |
118779672 | 11877967 | Autonomic nervous system imbalance | |
118779672 | 11877967 | Bradycardia | |
118779672 | 11877967 | Cognitive disorder | |
118779672 | 11877967 | Drug ineffective for unapproved indication | |
118779672 | 11877967 | Eye disorder | |
118779672 | 11877967 | Fibromyalgia | |
118779672 | 11877967 | Gastrointestinal disorder | |
118779672 | 11877967 | Gastrointestinal motility disorder | |
118779672 | 11877967 | Muscle atrophy | |
118779672 | 11877967 | Muscular weakness | |
118779672 | 11877967 | Myalgia | |
118779672 | 11877967 | Polyneuropathy | |
118779672 | 11877967 | Product quality issue | |
118779672 | 11877967 | Respiratory muscle weakness | |
118779672 | 11877967 | Tachycardia | |
118779672 | 11877967 | Tendon disorder | |
118779672 | 11877967 | Tendon pain | |
118779672 | 11877967 | Toxicity to various agents | |
118779672 | 11877967 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |